NewAmsterdam Pharma Company N.V.

NAMS· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$19.58-2.39%

2026-11-02

Financials

Valuation Metrics

NewAmsterdam Pharma Company N.V.'s Market Cap is $2.29B. At end of 2025 it was $4.01B. Ranked #1867 of 3,118 in US market (top 60%), #683 of 1,474 on NASDAQ (top 46%), #116 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 44%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	$2.29B	US#1,867/3,118 Sec#116/265
Revenue	$7M	US#2,811/3,118 Sec#172/265
Net Income	$-260M	US—/3,118 Sec—/265
Total Assets	$704M	US#2,615/3,118 Sec#129/265
Net Assets	$631M	US#2,068/3,118 Sec#91/265
Value
P/B	3.63x	US#1,999/3,118 Sec#118/265
P/S	321.44x	US#2,965/3,118 Sec#189/265
FCF Yield	-6.28%	US—/3,118 Sec—/265
Profitability
ROE	-41.10%	US#2,629/3,118 Sec#139/265
ROA	-36.84%	US#2,924/3,118 Sec#180/265
Op. Margin	-3432.20%	US#2,821/3,118 Sec#172/265
Revenue Growth	-88.87%	US#2,718/3,118 Sec#176/265
Financial Health
Debt Ratio	11.57%	US#126/3,118 Sec#56/265
Total Debt	$82000.00	US#3,000/3,118 Sec#257/265
FCF	$-144M	US#2,707/3,118 Sec#176/265
Cash	$424M	US#1,174/3,118 Sec#65/265
Current Ratio	9.03x	US#282/3,118 Sec#83/265
Performance
1Y Return	-48.41%	US#2,844/3,118 Sec#233/265
1M Return	-15.60%	US#2,737/3,118 Sec#217/265
From 52W High	-53.61%	US#2,682/3,118 Sec#205/265
1Y MDD	-52.88%	US#2,502/3,118 Sec#177/265
Trading
Volume	1,835,659 shares	US#1,379/3,118 Sec#125/265
Trading Value	$37M	US#1,790/3,118 Sec#130/265
Per Share
EPS	$-2.22	US—/3,118 Sec—/265
BPS	$5.40	US#2,242/3,118 Sec#122/265